(Q38699369)

5 September 2017

title

The Framingham Heart Study--67 years of discovery in metabolic disease (English)

1 reference

5 September 2017

publication date

18 January 2016

1 reference

Nature Reviews Endocrinology

5 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26775764%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26775764%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26775764%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

page(s)

177-183

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26775764%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nrendo.2015.226

11 June 2020

exact match

0 references

cites work

Relation of body weight to development of coronary heart disease. The Framingham study

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.226

Obesity, very low density lipoproteins, and glucose intolerance over fourteen years: The Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.226

Overweight and obesity as determinants of cardiovascular risk: the Framingham experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.226

Obesity and the risk of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.226

Obesity and the Risk of New-Onset Atrial Fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.226

Relation of body fat distribution to metabolic complications of obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.226

Regional obesity and risk of cardiovascular disease; the Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.226

Ectopic fat depots and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.226

Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.226

Body fat distribution, incident cardiovascular disease, cancer, and all-cause mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.226

Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.226

The role of adipose cell size and adipose tissue insulin sensitivity in the carbohydrate intolerance of human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.226

Depot-specific differences and insufficient subcutaneous adipose tissue angiogenesis in human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.226

Differential computed tomographic attenuation of metabolically active and inactive adipose tissues: preliminary findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.226

Visceral and subcutaneous fat quality and cardiometabolic risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.226

Fat quality and incident cardiovascular disease, all-cause mortality, and cancer mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.226

Adipose tissue extracellular matrix and vascular abnormalities in obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.226

Prevalence and Trends in Obesity Among US Adults, 1999-2000

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.226

Genome-wide association for abdominal subcutaneous and visceral adipose reveals a novel locus for visceral fat in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.226

Genome-wide association of pericardial fat identifies a unique locus for ectopic fat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.226

Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.226

Heritability and genome-wide association analysis of renal sinus fat accumulation in the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.226

Genetic studies of body mass index yield new insights for obesity biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.226

Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.226

New genetic loci link adipose and insulin biology to body fat distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.226

Diabetes and cardiovascular disease. The Framingham study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.226

Role of diabetes in congestive heart failure: the Framingham study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.226

Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.226

Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.226

Trends in the incidence of type 2 diabetes mellitus from the 1970s to the 1990s: the Framingham Heart Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.226

Trends in diabetes incidence: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.226

Increasing cardiovascular disease burden due to diabetes mellitus: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.226

Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950 to 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.226

Trends in cardiovascular disease risk factors in individuals with and without diabetes mellitus in the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.226

Trends in control of cardiovascular risk factors among US adults with type 2 diabetes from 1999 to 2010: comparison by prevalent cardiovascular disease status

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.226

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.226

Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.226

Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.226

NIDDM and blood pressure as risk factors for poor cognitive performance. The Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.226

Midlife type 2 diabetes and poor glycaemic control as risk factors for cognitive decline in early old age: a post-hoc analysis of the Whitehall II cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.226

Association of metabolic dysregulation with volumetric brain magnetic resonance imaging and cognitive markers of subclinical brain aging in middle-aged adults: the Framingham Offspring Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.226

A genome-wide scan for loci linked to plasma levels of glucose and HbA(1c) in a community-based sample of Caucasian pedigrees: The Framingham Offspring Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.226

New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.226

Genome-wide association with diabetes-related traits in the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.226

Variants in MTNR1B influence fasting glucose levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.226

Genotype score in addition to common risk factors for prediction of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.226

Polygenic type 2 diabetes prediction at the limit of common variant detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.226

Metabolite profiles and the risk of developing diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.226

Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.226

Metabolite traits and genetic risk provide complementary information for the prediction of future type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.226

Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.226

Parental obesity and offspring serum alanine and aspartate aminotransferase levels: the Framingham heart study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.226

Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.226

Aminotransferase levels are associated with cardiometabolic risk above and beyond visceral fat and insulin resistance: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.226

Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.226

Nonalcoholic fatty liver disease and vascular function: cross-sectional analysis in the Framingham heart study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.226

Hepatic steatosis is associated with lower levels of physical activity measured via accelerometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.226

Hepatic steatosis and cardiovascular disease outcomes: An analysis of the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.226

The Spread of Obesity in a Large Social Network over 32 Years

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.226

Factors of risk in the development of coronary heart disease--six year follow-up experience. The Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.226

Increasing Trends in Incidence of Overweight and Obesity over 5 Decades

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.226

Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.226

Diabetes, intermittent claudication, and risk of cardiovascular events. The Framingham Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.226

Trends in cardiovascular complications of diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.226

Coronary heart disease in the Framingham study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.226

31 March 2020

Identifiers

DOI

10.1038/NRENDO.2015.226

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26775764%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

1 reference